Capital International, Inc. Sarepta Therapeutics, Inc. Transaction History
Capital International, Inc.
- $7.83 Billion
- Q1 2025
A detailed history of Capital International, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Capital International, Inc. holds 27,490 shares of SRPT stock, worth $1.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
27,490
Previous 22,493
22.22%
Holding current value
$1.1 Million
Previous $2.73 Million
35.84%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
506Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$413 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$363 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$362 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$163 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$135 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.51B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...